sabrina essen sorted by
relevance

Admin15.06.2021

Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro

2 Institute of Pathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
9203
Admin16.08.2021

Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro

1 Institute of Pathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Admin22.07.2021

Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro

The gene expression pattern identified could be found in approx.
4303
Admin09.07.2021

Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro

4 Department of Pathology, Helios Klinikum Emil von Behring, Berlin, Germany.
1409
Admin27.07.2021

Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro

2 Institute of Pathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
3809
Admin18.06.2021

Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro

Hiltbrunner S, Mannarino L, Kirschner MB, Opitz I, Rigutto A, Laure A, Lia M, Nozza P, Maconi A, Marchini S, D'Incalci M, Curioni-Fontecedro A, Grosso F.
4708
Admin26.06.2021

Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro

Threshold was set at 600 counts.
8002
Admin26.07.2021

Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro

8 Department of Thoracic Surgery and Thoracic Endoscopy, Ruhrlandklinik, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
98010
Admin20.06.2021

Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro

Low expression is highlighted in red, high expression is highlighted in green.
80010
Admin15.08.2021

Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro

Furthermore, we aimed to find possible correlations between response and gene expression patterns associated with BRCAness phenotype.
8608